PMSA Board of Directors
The current PMSA Board members are listed below. They welcome your questions and feedback. You may also contact PMSA headquarters page.
- To see past PMSA Board members click here.
- Click here to apply for a board position - you must be logged in to access the link. Note: You must be a paid member to apply.
 |
President: Jin Tong email: This email address is being protected from spambots. You need JavaScript enabled to view it. Novartis |
 |
Vice President: Karthikeyan Chidambaram email: This email address is being protected from spambots. You need JavaScript enabled to view it. Genentech, Inc. 650.225.4620 |
|
 |
Treasurer/Secretary: Vishal Chaudhary email: This email address is being protected from spambots. You need JavaScript enabled to view it. Sanofi 302.468.9275 |
 |
Professional Development Chair: Nuray Yurt email: This email address is being protected from spambots. You need JavaScript enabled to view it. Novartis 867.778.9613 |
|
 |
Marketing Committee Chair: Haibei Jiang email: This email address is being protected from spambots. You need JavaScript enabled to view it. Bayer Pharmaceuticals 862.404.6131 |
 |
Research & Education Chair: Igor Rudychev email: This email address is being protected from spambots. You need JavaScript enabled to view it. AstraZeneca |
|
 |
Program Committee Chair: Arlene Little email: This email address is being protected from spambots. You need JavaScript enabled to view it. Genentech, Inc. |
 |
Program Committee: Nathan Wang email: This email address is being protected from spambots. You need JavaScript enabled to view it. Janssen Pharmaceuticals, Inc. |
|
 |
Program Committee: Mehul Shah email: This email address is being protected from spambots. You need JavaScript enabled to view it. Sanofi |
|||
 |
Executive Advisory Council: Cynthia Dilley email: This email address is being protected from spambots. You need JavaScript enabled to view it. UCB, Inc. 770.970.8565 |
 |
Executive Advisory Council: Jason Carlin email: This email address is being protected from spambots. You need JavaScript enabled to view it. Novartis 973.305.6180 |
|